Skip to main content
EU OKs HeartStitch's transapical access, closure device
4/13/2018

European regulators granted HeartStitch CE mark approval for its Trans-Apical Access and Closure device. The suture-based system is intended for providing percutaneous transapical access in left-heart structural heart defect repairs, imitating surgical closure without the need for open heart surgery or limited thoracotomy access.

Full Story: